Immunopathogenesis of membranous nephropathy: an update

Hanna Debiec1, Pierre Ronco

  • 1Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1155, 75005, Paris, France, hanna.debiec@upmc.fr.

Insights

Recent advances in understanding membranous nephropathy (MN), an autoimmune kidney disease, have identified key antigens and genes. This knowledge impacts diagnosis, monitoring, and therapy, opening new research avenues for better patient care.

Area of Science:

  • Nephrology
  • Immunology
  • Genetics

Background:

  • Membranous nephropathy (MN) is a kidney-specific autoimmune disease.
  • It involves immune deposits on the glomerular basement membrane, leading to proteinuria and potential renal failure.
  • Recent research has significantly advanced the understanding of MN's molecular basis.

Purpose of the Study:

  • To review recent findings on the molecular pathogenesis of membranous nephropathy.
  • To highlight the impact of these discoveries on diagnosis, monitoring, and therapy.
  • To explore future research perspectives and therapeutic opportunities.

Main Methods:

  • Review of recent scientific literature on membranous nephropathy.
  • Analysis of identified antigens and predisposing genes.
  • Discussion of the implications for understanding immune response and disease progression.

Main Results:

  • Identification of specific antigens and genetic factors contributing to MN in adults and children.
  • Demonstration of the impact of these findings on current clinical practice.
  • Recognition of the complexity involving multiple antigen-antibody systems and genes.

Conclusions:

  • Advances in understanding MN's molecular basis are transforming diagnosis and treatment.
  • Further research into MN's complex pathogenesis promises novel therapeutic interventions.
  • Insights from MN may also illuminate other organ-specific autoimmune diseases.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102